PPARG and steatosis: These predictions are consistent with experimental studies in which reduction of PPAR‐γ activity in obese mice, via antagonism or gene knockout, combined with activated PPAR‐α, resulted in decreased steatosis (Morán‐Salvador et al. 2011; Zhang et al. 2014; Shiomi et al. 2015).